Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· RevGeneticsAudio: English

Fisetin: Key to Slowing Aging by Targeting Senescent Cells in Mice - Study Podcast 005

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: English

In this podcast, researchers discuss the potential of Fisetin, found in strawberries, as a key ingredient in slowing down aging by targeting cellular senescence. Senescent cells, which stop dividing and release inflammatory signals, contribute to aging-related issues. The study, published in Biomedicine, suggests Fisetin as a potent senolytic, cleaning up these problematic cells. In vitro experiments showed Fisetin's effectiveness in eliminating senescent cells compared to other flavonoids. Further tests on mice with progeroid syndrome supported these findings. The research aims to find safer and more effective senolytics for combating age-related diseases. You would need to eat approximately 6.9 pounds of strawberries a day to get the equivalent of 500 mg of fisetin. RevGenetics Fisetin 500mg can be found here: https://www.revgenetics.com/collections/longevity-supplements/products/senolytics-500-fisetin-500mg

RevGenetics · 9 min · Source published: 2024-09-27

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…